Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Thomas Blom, Rutger Meinsma, Franca di Summa, Emile van den Akker, André B.P. van Kuilenburg, Marten Hansen, Godelieve A.M. Tytgat
Research output: Contribution to journal › Article › peer-review
1Citation
(Scopus)
Fingerprint
Dive into the research topics of 'Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes'. Together they form a unique fingerprint.